| 1 |
Ghrelin
Timo D. Müller et al. · Molecular Metabolism
Open access |
7 Apr 2015 |
1,036 |
| 2 |
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
Richard M. Lawn, David P. Wade, Michael R. Garvin et al. · Journal of Clinical Investigation
Open access |
15 Oct 1999 |
729 |
| 3 |
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Peter Kühnen, Karine Clément, Susanna Wiegand et al. · New England Journal of Medicine
|
20 Jul 2016 |
489 |
| 4 |
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clément et al. · The Lancet Diabetes & Endocrinology
|
30 Oct 2020 |
481 |
| 5 |
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model
Masashi Kitazawa, David Cheng, Michelle R. Tsukamoto et al. · The Journal of Immunology
Open access |
17 Nov 2011 |
472 |
| 6 |
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
Robert Randolph Edwards et al. · Pain
Open access |
5 May 2016 |
410 |
| 7 |
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
Paul Gerard Guy Richardson et al. · Blood
Open access |
29 Jan 2016 |
335 |
| 8 |
A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Michael J. Thorpy, Colin M. Shapiro, Geert Mayer et al. · Annals of Neurology
Open access |
29 Jan 2019 |
326 |
| 9 |
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial
Paula Klingenberg Schweitzer, Russell P. Rosenberg, Gary K Zammit et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
6 Dec 2018 |
320 |
| 10 |
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
Karine Clément et al. · Nature Medicine
|
May 2018 |
319 |
| 11 |
Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Persons with AIDS
Stephen A. Spector, George F. McKinley, Jacob Paul Lalezari et al. · New England Journal of Medicine
Open access |
6 Jun 1996 |
311 |
| 12 |
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
Tinh‐Hai Collet et al. · Molecular Metabolism
Open access |
8 Jul 2017 |
310 |
| 13 |
Incidence and long-term cost of steroid-related side effects after renal transplantation
David Leroy Veenstra, Jennie H. Best, John M. Hornberger et al. · American Journal of Kidney Diseases
|
May 1999 |
305 |
| 14 |
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse
Lawrence P. Carter, Daniel Pardi, Jane Gorsline et al. · Drug and Alcohol Dependence
Open access |
3 Jun 2009 |
282 |
| 15 |
Safety Overview of Postmarketing and Clinical Experience of Sodium Oxybate (Xyrem): Abuse, Misuse, Dependence, and Diversion
Y. Grace Wang, Todd J. Swick, Lawrence P. Carter et al. · Journal of Clinical Sleep Medicine
Open access |
15 Aug 2009 |
271 |
| 16 |
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna, Carlo Albera, Aryeh Fischer et al. · The Journal of Rheumatology
Open access |
Jul 2016 |
270 |
| 17 |
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy
Giles S.H. Yeo, Daniela Herrera Moro Chao, Anna‐Maria Siegert et al. · Molecular Metabolism
Open access |
7 Mar 2021 |
252 |
| 18 |
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
Atul Malhotra, Colin Michael Shapiro, Jean‐Louis Pépin et al. · SLEEP
Open access |
6 Nov 2019 |
250 |
| 19 |
Effects of Sodium Oxybate on Sleep Physiology and Sleep/Wake-related Symptoms in Patients with Fibromyalgia Syndrome: A Double-blind, Randomized, Placebo-controlled Study
Harvey Moldofsky, Neil Inhaber, Diane Guinta et al. · The Journal of Rheumatology
Open access |
3 Aug 2010 |
236 |
| 20 |
Sodium Oxybate Improves Excessive Daytime Sleepiness in Narcolepsy
Jed E. Black, William C. Houghton · SLEEP
|
Jul 2006 |
235 |
| 21 |
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial
Jeffrey E. Lancet, Geoffrey L. Uy, Laura F. Newell et al. · The Lancet Haematology
|
22 Jun 2021 |
228 |
| 22 |
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations
Ann Taylor et al. · Pain
Open access |
7 Apr 2016 |
215 |
| 23 |
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
Barbara L. Asselin, Meenakshi Devidas, Lu Chen et al. · Journal of Clinical Oncology
Open access |
23 Dec 2015 |
205 |
| 24 |
The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin
MARIAN N. MARRA, CRAIG G. WILDE, Michael Collins et al. · The Journal of Immunology
|
1992 |
205 |
| 25 |
Circadian Rhythm Abnormalities
Phyllis C. Zee, Hrayr Pierre Attarian, Aleksandar Videnović · CONTINUUM Lifelong Learning in Neurology
Open access |
Feb 2013 |
204 |
| 26 |
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Andrea Maria Haqq, Wendy K. Chung, Hélène Dollfus et al. · The Lancet Diabetes & Endocrinology
Open access |
7 Nov 2022 |
201 |
| 27 |
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy
Hélène A. Emsellem, Michael J. Thorpy, Gert Jan Lammers et al. · Sleep Medicine
Open access |
4 Dec 2019 |
193 |
| 28 |
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang et al. · Journal of Psychopharmacology
Open access |
Oct 2018 |
185 |
| 29 |
RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals
Kong Y. Chen, Ranganath Muniyappa, Brent S. Abel et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
12 Feb 2015 |
178 |
| 30 |
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
David O’Connor, Amir Enshaei, Jack Luke Bartram et al. · Journal of Clinical Oncology
Open access |
13 Nov 2017 |
176 |
| 31 |
An Algorithm for Approximate Tandem Repeats
Gad M. Landau, Jeanette P. Schmidt, Dina Sokol · Journal of Computational Biology
|
Feb 2001 |
175 |
| 32 |
Behavioral analyses of GHB: Receptor mechanisms
Lawrence P. Carter, Wouter Koek, Charles Patrick France · Pharmacology & Therapeutics
Open access |
30 Oct 2008 |
148 |
| 33 |
Research design considerations for chronic pain prevention clinical trials
Jennifer S. Gewandter et al. · Pain
Open access |
16 Apr 2015 |
145 |
| 34 |
A Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy
The Xyrem reg, International Study Group · Journal of Clinical Sleep Medicine
Open access |
15 Oct 2005 |
143 |
| 35 |
Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study
Jed E. Black, Nancy L. Reaven, Susan E. Funk et al. · Sleep Medicine
|
12 May 2016 |
134 |
| 36 |
Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
Robert M. Haws, Sheila M. Brady, Elisabeth K. Davis et al. · Diabetes Obesity and Metabolism
Open access |
6 Jul 2020 |
129 |
| 37 |
Final results from a defibrotide treatment‐ IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome
Nancy A. Kernan, Stephan A. Grupp, Angela R. Smith et al. · British Journal of Haematology
Open access |
16 May 2018 |
127 |
| 38 |
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017
Patrick Andrew Brown et al. · Journal of the National Comprehensive Cancer Network
Open access |
Sep 2017 |
127 |
| 39 |
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D. Mayer, Paul G. Tardi, Arthur Chin Louie · International Journal of Nanomedicine
Open access |
May 2019 |
124 |
| 40 |
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
Kris Rutten, Jennifer Basile, Jos Prickaerts et al. · Psychopharmacology
Open access |
22 Nov 2007 |
124 |
| 41 |
Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease
William G. Ondo, Thomas T. Perkins, Todd J. Swick et al. · Archives of Neurology
|
Oct 2008 |
124 |
| 42 |
Comorbidities, Health-Related Quality of Life, and Work Productivity Among People With Obstructive Sleep Apnea With Excessive Sleepiness: Findings From the 2016 US National Health and Wellness Survey
Carl J. Stepnowsky, Kathleen F. Sarmiento, Shay Bujanover et al. · Journal of Clinical Sleep Medicine
Open access |
14 Feb 2019 |
122 |
| 43 |
??-Hydroxybutyrate/Sodium Oxybate
Daniel Pardi, Jed E. Black · CNS Drugs
|
2006 |
121 |
| 44 |
Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade
Emily S. Tonorezos, Dana Barnea, Richard Jules Cohn et al. · Journal of Clinical Oncology
Open access |
6 Jun 2018 |
115 |
| 45 |
Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
Mieke A. Dentener, E J Von Asmuth, Gaby J.M. Francot et al. · The Journal of Immunology
|
Oct 1993 |
114 |
| 46 |
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations
Jennifer S. Gewandter et al. · Pain
Open access |
24 May 2014 |
111 |
| 47 |
High Rates of Psychiatric Comorbidity in Narcolepsy
Chad M. Ruoff, Nancy L. Reaven, Susan E. Funk et al. · The Journal of Clinical Psychiatry
|
7 Nov 2016 |
108 |
| 48 |
Brief Report: Excitatory and Inhibitory Brain Metabolites as Targets of Motor Cortex Transcranial Direct Current Stimulation Therapy and Predictors of Its Efficacy in Fibromyalgia
Bradley R. Foerster, Thiago Dias Nascimento, Misty Dawn Deboer et al. · Arthritis & Rheumatology
Open access |
4 Nov 2014 |
107 |
| 49 |
Disorders of reproduction in patients with epilepsy: Antiepileptic drug related mechanisms
Jouko I. T. Isojärvi · Seizure
Open access |
5 Feb 2008 |
106 |
| 50 |
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus et al. · Neuropsychopharmacology
Open access |
20 Jun 2023 |
105 |